Co-infection with Hepatitis B, C and Human immunodeficiency Virus in Nigerian Children with Sickle Cell Anaemia
DOI:
https://doi.org/10.60787/tnhj.v15i1.185Keywords:
HBsAg, Anti- HCV antibody, HIV, SCA, Co-infectionAbstract
Background: Nigeria which has one of the world's highest burdens of children living with Sickle cell anaemia is also endemic for hepatitis B, C and the Human immunodeficiency virus (HIV). This study set out to determine the prevalence of Hepatitis B surface antigen (HBsAg), antibodies to Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among children with Sickle cell anaemia (SCA) at the University Of Port Harcourt Teaching Hospital (UPTH).
Methods: This was a prospective hospital based study of children with sickle cell anaemia aged 0.5 years to 18yearspresenting at the haematology clinic of UPTH. A serological screening was carried out over a period of five months to determine the presence of hepatitis B virus (HBV), HCV and HIV 1 and 2 infections. Other data obtained included sex, age and other demographic data.
Results: There were 132 SCA patients with 72 (54.5%) males and 60 (45.5%) females. Results of HCV anti-body, HBSAg, and HIV were available for 84 patients. Mean age was 7.45 ±1.6 years, age range was 0.5-18years Seventy-eight (59.1%) had no previous blood transfusion, forty (30.3%) had one previous transfusion while eight (6.1%) had more than one previous transfusions. HBsAg was positive in three patients giving a prevalence of 3.6%; Anti-HCV antibody was not found in any patient while two (2.4%) were positive for HIV 1. There was no patient with Hepatitis, HIV and SCA.
Conclusion: This study showed no co-infection with Hepatitis B, C and HIV viral infection among children with SCA at UPTH, Nigeria.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
